Counseling program for lymphoma survivors to reduce fatigue
Official title: Living Well With Lymphoma: Improving Diet Quality to Improve Energy, Sleep and Quality of Life
Run by University of Michigan Rogel Cancer Center · NCT06047626 · Data updated 2026-11-12
This study is testing if a special counseling program about diet can help lymphoma survivors who are feeling very tired to feel better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Michigan Rogel Cancer Center Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Status | Recruiting |
| Started | March 7, 2024 |
| Main results expected | September 2027 |
| Study ends | September 2028 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT06047626 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have been diagnosed with lymphoma and experience persistent fatigue attributed to their condition.
✕Probably not a fit
Patients who are medically unstable or have untreated mood disorders, anemia, or hypothyroidism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a three-month individualized counseling program focused on a Fatigue Reduction Diet (FRD) delivered by registered dietitians to lymphoma survivors experiencing persistent fatigue. Participants will be randomized to receive either the FRD counseling or an attention control group receiving a General Health Curriculum (GHC), with both groups having similar interaction frequency. The study aims to assess improvements in fatigue, quality of life, and related symptoms, as well as biological markers of inflammation, over a 15-month follow-up period. A total of 68 lymphoma survivors will be enrolled, accounting for potential dropouts.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and reduce fatigue in lymphoma survivors.
How similar studies have gone: Other studies have shown promising results with dietary interventions for cancer-related fatigue, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women and men aged 18 years and older * Diagnosis of lymphoma (Hodgkin and non-Hodgkin) * Have an average persistent fatigue defined as ≥ 4 on the Brief Fatigue Inventory * Fatigue must be attributed to lymphoma diagnosis * Fatigue onset must be between 12months before diagnosis and any time after diagnosis * Fatigue must not be attributed to other disease diagnoses * Fruit and vegetable intake ≤5.5 servings/day * Have, or be willing to create, an email address to receive study questionnaires electronically. Exclusion Criteria: * Medically unstable * BMI\<18.5 kg/m2 * Have a current untreated diagnosis of mood disorder, e.g., bipolar or major depressive disorder * Have a current untreated diagnosis of anemia * Have a current untreated diagnosis of hypothyroidism * Have an initiation, a cessation or change of treatment of any chronic medications, dietary supplements, behavioral therapy, physical therapy etc., or any planned change of medications, supplements, or therapies during the study * Have a current diagnoses of cachexia * Planning on becoming pregnant, currently pregnant or lactating
Where it's running
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting
Study contacts
- Principal investigator: Suzie Zick — University of Michigan Rogel Cancer Center
- Study coordinator: Sara Snyder
- Email: fammed-szickstudy@med.umich.edu
- Phone: 734-998-7124
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
LB-208: a new oral treatment for adults with advanced solid tumors or lymphoma
This early study tests whether LB-208, taken once daily by mouth, is safe for adults with advanced solid tumors or lymphoma who have exhausted standard treatments.
-
Tailored exercise program to improve quality of life for adults with hematologic cancers
This pilot trial tests a personalized 16-week exercise program to see if it’s feasible and helpful for adults with acute myeloid leukemia, lymphoma, or multiple myeloma after first-line treatment.
-
CD19/CD22 CAR-T consolidation after second-line therapy for high-risk aggressive B-cell lymphoma
This trial tests whether CD19/CD22 CAR-T cell therapy given after a second-line response can help people with high-risk aggressive B-cell lymphoma stay in remission.
-
Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia
This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Glofit-GemOx Bridging to Liso-cel for Relapsed/Refractory Large B-Cell Lymphoma
This trial tests whether a bridging therapy with Glofit-GemOx followed by lisocabtagene maraleucel helps people with relapsed or refractory large B-cell lymphoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.